{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260625629388/en/Incyte-Announces-Positive-CHMP-Opinion-for-Opzelura%C2%AE-ruxolitinib-Cream-for-the-Treatment-of-Adults-with-Moderate-Atopic-Dermatitis", "message": "News view counter 818394 successfully enlarged"}